Sökning: "Sektion II"
Visar resultat 6 - 10 av 713 avhandlingar innehållade orden Sektion II.
6. Clinical and experimental insights into the use of mechanical chest compressions during prolonged resuscitation in the coronary catheterization laboratory
Sammanfattning : INTRODUCTION. Prolonged cardiopulmonary resuscitation (CPR) with manual chest compressions (CC) during simultaneous percutaneous coronary intervention (PCI) is exceedingly difficult, with high mortality rates. The use of a mechanical CC (MCC) device can overcome the ordeal of manual CC. LÄS MER
7. Long-term prognosis with home hemodialysis. A comparison with other renal replacement therapies
Sammanfattning : Background: The annual mortality for patients on dialysis is high even if it has decreased from 30 % in 1991 to 18 % in 2016. It is mainly caused by an increased cardiovascular and infectious morbidity. Previous studies have reported improved survival for patients with home hemodialysis (HHD). LÄS MER
8. Hypothermia as an adjunctive therapy in Acute Myocardial Infarction and Cardiogenic Shock
Sammanfattning : INTRODUCTION: Reperfusion therapy in patients with an ongoing ST-elevation myocardial infarction (STEMI) is to re-establish coronary flow in the epicardial arteries as soon as possible in order to reduce infarct size and associated complications. Hypothermia has in experimental studies been shown to reduce infarct size. LÄS MER
9. Transcatheter Aortic Valve Implantation: Risk Assessment and Clinical Outcome
Sammanfattning : Abstract Background: Transcatheter aortic valve implantation (TAVI) has emerged as a treatment for patients with aortic stenosis (AS) and high surgical risk. To date, reports of short- and mid-term survival have been favourable. The aim of this thesis was to evaluate early safety, risk assessment and late survival following TAVI. LÄS MER
10. Atrial Fibrillation. Modulation of the atrial fibrillatory frequency. A non-invasive approach
Sammanfattning : Aim: To non-invasively detect and explore the changes in atrial fibrillatory cycle length (i.e. changes in the atrial refractory period) in humans with chronic atrial fibrillation (CAF) following autonomic modulation and pharmacological intervention. LÄS MER